Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market.

Pharmacology Watch: The FDA and Merck Fielding Concerns About Vioxx